|
de la Morena-Barrio ME, García A, Martínez-Martínez I, Miñano A, Padilla J, Navarro-Fernández J, Roldán V, Águila S, Iniesta JA, Corral J, Vicente V. A new method to quantify ?-antithrombin glycoform in plasma reveals increased levels during the acute stroke event. Thromb Res. 2015 Sep;136(3):634-41. doi: 10.1016/j.thromres.2015.06.039. PubMed PMID: 26186963.
AÑO: 2015; IF: 3.944
|
26186963
|
Navarro-Fernández J, de la Morena-Barrio ME, Padilla J, Miñano A, Bohdan N, Águila S, Martínez-Martínez I, Sevivas TS, de Cos C, Fernández-Mosteirín N, Llamas P, Asenjo S, Medina P, Souto JC, Overvad K, Kristensen SR, Corral J, Vicente V. Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency. Thromb Haemost. 2016 Jul 4;116(1):146-54. doi: 10.1160/TH15-11-0871. Epub 2016 Apr 21. PubMed PMID: 27098529.
AÑO: 2016; IF: 5.627
|
|
de la Morena-Barrio M, Sandoval E, Llamas P, Wypasek E, Toderici M, Navarro-Fernández J, Rodríguez-Alen A, Revilla N, López-Gálvez R, Miñano A, Padilla J, de la Morena-Barrio B, Cuesta J, Corral J, Vicente V. High levels of latent antithrombin in plasma from patients with antithrombin deficiency. Thromb Haemost. 2017 May 3;117(5):880-888. doi: 10.1160/TH16-11-0866. Epub 2017 Feb 23. PubMed PMID: 28229161.
AÑO: 2017; IF: 4.952
|
|
Navarro-Fernández J, Eugenia de la Morena-Barrio M, Martínez-Alonso E, Dybedal I, Toderici M, Bohdan N, Miñano A, Heimdal K, Abildgaard U, Martínez-Menárguez JÁ, Corral J, Vicente V. Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family. Oncotarget. 2018 Sep 4;9(69):33202-33214. doi: 10.18632/oncotarget.26059. eCollection 2018 Sep 4. PubMed PMID: 30237862; PubMed Central PMCID: PMC6145704.
AÑO: 2018
|